Neuracle Genetics

Developer of an adeno-associated virus gene therapy designed to improve the quality of life of patients. The company utilizes AAV gene therapy applications for treating neurodegenerative disorders and...

Healthcare
Seoul, South Korea
Founded 2018
31 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$81.4M
Last Round
N/A

Get the full picture

Create a free account to unlock Neuracle Genetics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required